Semaglutide speeds resolution of brain inflammation in mouse study
Mice pretreated for two weeks showed reduced hippocampal microglial activation 11 days after a lipopolysaccharide challenge, though the initial immune spike was unchanged.
PR
By Priya Raman · Science Reporter
Sep 18 12:22 ETSource: PsyPost
The wire
- 01In work published in Nature Communications, male mice received daily semaglutide for two weeks before a lipopolysaccharide injection; single-nucleus RNA sequencing of hippocampal cells tracked microglial and astrocyte programs over time.
- 02The paper offers a cellular mechanism for observational reports of lower dementia rates among GLP-1 users, a question clinicians are increasingly asked about.
- 03This is a male-mouse model of acute bacterial-toxin inflammation, not a cognitive outcome study, and semaglutide did not blunt the initial microglial response.
From the source
Read at psypost.orgWeight-loss drug semaglutide accelerates recovery from brain inflammation in mice
The diabetes and weight-loss drug semaglutide can calm inflammation in the brain by coordinating a response across multiple types of cells. The findings suggest the medication might help protect against cognitive decline by reversing cellular changes associated with neurodegenerative diseases. The research was published in Nature Communications .